Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of GlucoTab with insulin degludec in non-critically ill type 2 diabetes inpatients
2018-002646-36Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Aug 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of insulin degludec in type 2 diabetes mellitus (T2DM) and hyperglycemia, sponsored by Medical University of Graz. Primary endpoint: Mean percentage of blood glucose measurements in target range. Started Aug 2018; status: completed.
02
Drugs
insulin degludec
03
Conditions
type 2 diabetes mellitus (T2DM)hyperglycemia
Beyond the preview
Go deeper on 2018-002646-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002646-36.